{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:27:59Z","timestamp":1787502479953,"version":"build-2736575974"},"reference-count":71,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.sapharm.2026.01.006","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:38:36Z","timestamp":1769733516000},"page":"561-573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacists\u2019 barriers and enablers to deprescribing: A systematic review and meta-synthesis"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7597-8036","authenticated-orcid":false,"given":"Jennifer","family":"Bolt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prab","family":"Khattra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Inglis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.sapharm.2026.01.006_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jac5.1537","article-title":"Factors influencing providers' willingness to deprescribe medications","volume":"5","author":"Davila","year":"2022","journal-title":"JACCP J Am Coll Clin Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2026.01.006_bib2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"Masnoon","year":"2017","journal-title":"BMC Geriatr"},{"issue":"4","key":"10.1016\/j.sapharm.2026.01.006_bib3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/ijpp\/riad025","article-title":"A systematic review of randomised-controlled trials on deprescribing outcomes in older adults with polypharmacy","volume":"31","author":"Omuya","year":"2023","journal-title":"Int J Pharm Pract"},{"issue":"2","key":"10.1016\/j.sapharm.2026.01.006_bib4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/jamainternmed.2019.5096","article-title":"Effect of clinical geriatric assessments and collaborative medication reviews by geriatrician and family physician for improving health-related quality of life in home-dwelling older patients receiving polypharmacy: a cluster randomized clinical trial","volume":"180","author":"Romskaug","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"9","key":"10.1016\/j.sapharm.2026.01.006_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14356","article-title":"Deprescribing practice in a resource-limited setting: Healthcare providers' insights","volume":"75","author":"Tegegn","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"3","key":"10.1016\/j.sapharm.2026.01.006_bib6","doi-asserted-by":"crossref","DOI":"10.3399\/bjgpopen20X101096","article-title":"Barriers and facilitators to deprescribing in primary care: a systematic review","volume":"4","author":"Doherty","year":"2020","journal-title":"BJGP Open"},{"issue":"13","key":"10.1016\/j.sapharm.2026.01.006_bib7","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1177\/1049732316687732","article-title":"Negotiating \u201cunmeasurable harm and benefit\u201d: perspectives of general practitioners and consultant pharmacists on deprescribing in the primary care setting","volume":"27","author":"Anderson","year":"2017","journal-title":"Qual Health Res"},{"issue":"2","key":"10.1016\/j.sapharm.2026.01.006_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/jphs.12303","article-title":"Deprescribing: an emerging role for pharmacists","volume":"10","author":"Bleidt","year":"2019","journal-title":"J Pharm Health Serv Res"},{"issue":"2","key":"10.1016\/j.sapharm.2026.01.006_bib9","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/bcp.14947","article-title":"Community-based pharmacists' role in deprescribing: a systematic review","volume":"88","author":"Bu\u017ean\u010di\u0107","year":"2022","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.sapharm.2026.01.006_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3390\/pharmacy13040109","article-title":"Pharmacist-led interventions for polypharmacy management in older adults: a systematic review of strategies and outcomes in the United Kingdom and the Republic of Ireland","volume":"13","author":"McGrory","year":"2025","journal-title":"Pharmacy"},{"issue":"8","key":"10.1016\/j.sapharm.2026.01.006_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-081934","article-title":"Pharmacist-led primary care interventions to promote medicines optimisation and reduce overprescribing: a systematic review of UK studies and initiatives","volume":"14","author":"Chambers","year":"2024","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.sapharm.2026.01.006_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/pharmacy13010003","article-title":"Pharmacist-mediated deprescribing in long-term care facilities: a systematic review","volume":"13","author":"Goncalves","year":"2025","journal-title":"Pharmacy"},{"key":"10.1016\/j.sapharm.2026.01.006_bib13","article-title":"The role of U.S. pharmacists in deprescribing: recommendations based on a systematic literature review of qualitative studies","volume":"19","author":"Cernasev","year":"2025","journal-title":"Explor Res Clin Soc Pharm"},{"issue":"8","key":"10.1016\/j.sapharm.2026.01.006_bib14","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.sapharm.2024.04.014","article-title":"Stakeholders' perspectives and experiences of the pharmacist's role in deprescribing in ambulatory care: a qualitative meta-synthesis","volume":"20","author":"Kassis","year":"2024","journal-title":"Res Soc Adm Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2026.01.006_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1471-2288-12-181","article-title":"Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ","volume":"12","author":"Tong","year":"2012","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.sapharm.2026.01.006_bib16","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.sapharm.2026.01.006_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-8-45","article-title":"Methods for the thematic synthesis of qualitative research in systematic reviews","volume":"8","author":"Thomas","year":"2008","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"10.1016\/j.sapharm.2026.01.006_bib18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1748-5908-6-42","article-title":"The behaviour change wheel: a new method for characterising and designing behaviour change interventions","volume":"6","author":"Michie","year":"2011","journal-title":"Implement Sci"},{"issue":"1","key":"10.1016\/j.sapharm.2026.01.006_bib19","first-page":"31","article-title":"Optimising the value of the critical appraisal skills programme (CASP) tool for quality appraisal in qualitative evidence synthesis","volume":"1","author":"Long","year":"2020","journal-title":"Res Methods Med Health Sci"},{"key":"10.1016\/j.sapharm.2026.01.006_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/2399202620922507","article-title":"Influencers on deprescribing practice of primary healthcare providers in Nova Scotia: an examination using behavior change frameworks","volume":"4","author":"Kennie-Kaulbach","year":"2020","journal-title":"Med Access Point Care"},{"issue":"1","key":"10.1016\/j.sapharm.2026.01.006_bib64","doi-asserted-by":"crossref","DOI":"10.1111\/bcpt.70060","article-title":"Barriers and facilitators to pharmacist-led deprescribing of antihypertensives in long-term care: a survey-based study","volume":"137","author":"Vucenovic","year":"2025","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"10.1016\/j.sapharm.2026.01.006_bib32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40266-021-00918-7","article-title":"Barriers and enablers of healthcare providers to deprescribe cardiometabolic medication in older patients: a focus group study","volume":"39","author":"Abou","year":"2022","journal-title":"Drugs Aging"},{"issue":"5","key":"10.1016\/j.sapharm.2026.01.006_bib29","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.sapharm.2023.01.013","article-title":"Barriers and enablers to deprescribing for older people in care homes: the theory-based perspectives of pharmacist independent prescribers","volume":"19","author":"Alharthi","year":"2023","journal-title":"Res Soc Adm Pharm RSAP"},{"issue":"4","key":"10.1016\/j.sapharm.2026.01.006_bib55","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/pharmacy12040116","article-title":"Deprescribing NSAIDs: the potential role of community pharmacists","volume":"12","author":"Amedi","year":"2024","journal-title":"Pharmacy"},{"issue":"9","key":"10.1016\/j.sapharm.2026.01.006_bib47","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-030950","article-title":"Delivering the right information to the right person at the right time to facilitate deprescribing in hospital: a mixed methods multisite study to inform decision support design in Australia","volume":"9","author":"Baysari","year":"2019","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.sapharm.2026.01.006_bib38","doi-asserted-by":"crossref","first-page":"e6521","DOI":"10.1111\/hsc.14099","article-title":"Enhancing deprescribing: a qualitative understanding of the complexities of pharmacist-led deprescribing in care homes","volume":"30","author":"Birt","year":"2022","journal-title":"Health Soc Care Community"},{"issue":"6","key":"10.1016\/j.sapharm.2026.01.006_bib44","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.3390\/ijerph20064957","article-title":"Differences in factors influencing deprescribing between primary care providers: cross-sectional study","volume":"20","author":"Bu\u017ean\u010di\u0107","year":"2023","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.sapharm.2026.01.006_bib56","doi-asserted-by":"crossref","DOI":"10.1111\/hex.13888","article-title":"Reducing long-term benzodiazepine receptor agonists: in-depth interview study of primary care stakeholders","volume":"27","author":"Coteur","year":"2024","journal-title":"Health Expect"},{"issue":"1","key":"10.1016\/j.sapharm.2026.01.006_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0316363","article-title":"Enablers and barriers to community pharmacists' readiness to implement deprescribing of inappropriate medications for older adults in Qatar","volume":"20","author":"Elshazly","year":"2025","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.sapharm.2026.01.006_bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00228-018-2578-2","article-title":"Qualitative analysis of community pharmacists' opinions on their involvement in reducing potentially inappropriate prescribing","volume":"75","author":"Hansen","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.sapharm.2026.01.006_bib43","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/ijpp\/riad027","article-title":"Are pharmacists' knowledge and practice the key to promoting deprescribing of potentially inappropriate medication: a missing link between treatment and outcomes","volume":"31","author":"El-Dahiyat","year":"2023","journal-title":"Int J Pharm Pract"},{"key":"10.1016\/j.sapharm.2026.01.006_bib41","article-title":"Barriers and enablers towards benzodiazepine-receptor agonists deprescribing in nursing homes: a qualitative study of stakeholder groups","volume":"9","author":"Evrard","year":"2023","journal-title":"Explor Res Clin Soc Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2026.01.006_bib54","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/1715163519882969","article-title":"Community pharmacists as catalysts for deprescribing: an exploratory study using quality improvement processes","volume":"153","author":"Farrell","year":"2020","journal-title":"Can Pharm J"},{"issue":"1","key":"10.1016\/j.sapharm.2026.01.006_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/bcpt.13910","article-title":"Exploration of the barriers and enablers of benzodiazepines deprescribing in prisons: a qualitative study among health and social care professionals","volume":"134","author":"Fay","year":"2024","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.sapharm.2026.01.006_bib33","first-page":"17","article-title":"Physicians', Nurses' and Pharmacists' perceptions of determinants to deprescribing in nursing homes considering three levels of action: a qualitative study","volume":"8","author":"Foley","year":"2020","journal-title":"Pharm Basel Switz"},{"issue":"6","key":"10.1016\/j.sapharm.2026.01.006_bib23","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s11096-021-01277-4","article-title":"Community pharmacists' perceptions on providing fall prevention services: a mixed-methods study","volume":"43","author":"Gemmeke","year":"2021","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.sapharm.2026.01.006_bib26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12875-020-01255-1","article-title":"Professional roles of general practitioners, community pharmacists and specialist providers in collaborative medication deprescribing - a qualitative study","volume":"21","author":"Gerlach","year":"2020","journal-title":"BMC Fam Pract"},{"issue":"10","key":"10.1016\/j.sapharm.2026.01.006_bib21","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.2215\/CJN.0000000000000229","article-title":"Stakeholder perspectives on factors related to deprescribing potentially inappropriate medications in older adults receiving dialysis","volume":"18","author":"Hall","year":"2023","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"7","key":"10.1016\/j.sapharm.2026.01.006_bib35","first-page":"1559","article-title":"Primary care and mental health prescribers, key clinical leaders, and clinical pharmacist specialists' perspectives on opioids and benzodiazepines","volume":"22","author":"Hawkins","year":"2021","journal-title":"Pain Med Malden Mass"},{"issue":"12","key":"10.1016\/j.sapharm.2026.01.006_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0274552","article-title":"Barriers and enablers to deprescribing in long-term care: a qualitative investigation into the opinions of healthcare professionals in Ireland","volume":"17","author":"Heinrich","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.sapharm.2026.01.006_bib25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/ijpp\/riab079","article-title":"Assessing community pharmacists' attitudes towards identifying opportunities for deprescribing in clinical practice in Ireland","volume":"30","author":"Heinrich","year":"2022","journal-title":"Int J Pharm Pract"},{"issue":"6","key":"10.1016\/j.sapharm.2026.01.006_bib42","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/jgs.17092","article-title":"Primary care clinician and community pharmacist perceptions of deprescribing","volume":"69","author":"Huffmyer","year":"2021","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.sapharm.2026.01.006_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-066234","article-title":"Identifying barriers and facilitators to deprescribing benzodiazepines and sedative hypnotics in the hospital setting using the theoretical domains framework and the capability, opportunity, motivation and behaviour (COM-B) model: a qualitative study","volume":"13","author":"Keller","year":"2023","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.sapharm.2026.01.006_bib31","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.sapharm.2020.01.019","article-title":"Exploring deprescribing opportunities for community pharmacists using the behaviour change wheel","volume":"16","author":"Korenvain","year":"2020","journal-title":"Res Soc Adm Pharm RSAP"},{"issue":"4","key":"10.1016\/j.sapharm.2026.01.006_bib58","doi-asserted-by":"crossref","DOI":"10.1111\/bcpt.70106","article-title":"Insights into pharmacist-led deprescribing of benzodiazepines and related drugs: a qualitative study with physicians and pharmacists","volume":"137","author":"Korppas","year":"2025","journal-title":"Basic & Clin Pharmacology Toxicol"},{"issue":"8","key":"10.1016\/j.sapharm.2026.01.006_bib28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/1060028016652997","article-title":"Health care practitioners' perspectives on deprescribing anticholinergic and sedative medications in older adults","volume":"50","author":"Kouladjian","year":"2016","journal-title":"Ann Pharmacother"},{"issue":"10","key":"10.1016\/j.sapharm.2026.01.006_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-030106","article-title":"Perspectives of health professionals towards deprescribing practice in Asian nursing homes: a qualitative interview study","volume":"9","author":"Kua","year":"2019","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.sapharm.2026.01.006_bib53","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/jgs.18047","article-title":"Challenges and opportunities in creating a deprescribing program in the emergency department: a qualitative study","volume":"71","author":"Lee","year":"2023","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"10.1016\/j.sapharm.2026.01.006_bib48","first-page":"277","article-title":"Clinical provider perceptions of proactive medication discontinuation","volume":"21","author":"Linsky","year":"2015","journal-title":"Am J Manag Care"},{"issue":"9","key":"10.1016\/j.sapharm.2026.01.006_bib59","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1002\/bcp.70088","article-title":"Patient, carer and healthcare professional perspectives on deprescribing in surgical wards: a mixed methods study","volume":"91","author":"Liu","year":"2025","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.sapharm.2026.01.006_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2025.108091","article-title":"Barriers and enablers to deprescribing for people living with cystic fibrosis: multidisciplinary perspectives","author":"Lord","year":"2025","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.sapharm.2026.01.006_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/ajhp\/zxac282","article-title":"Provider beliefs about the ideal design of an opioid deprescribing and substitution intervention for older adults","volume":"80","author":"Margraf","year":"2023","journal-title":"Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm"},{"issue":"2","key":"10.1016\/j.sapharm.2026.01.006_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40266-019-00728-y","article-title":"Reducing inappropriate drug use in older patients by use of clinical decision support in community pharmacy: a mixed-methods evaluation","volume":"37","author":"Mulder-Wildemors","year":"2020","journal-title":"Drugs Aging"},{"issue":"1","key":"10.1016\/j.sapharm.2026.01.006_bib49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12877-016-0181-x","article-title":"Barricades and brickwalls \u2013 a qualitative study exploring perceptions of medication use and deprescribing in long-term care","volume":"16","author":"Palagyi","year":"2016","journal-title":"BMC Geriatr"},{"issue":"8","key":"10.1016\/j.sapharm.2026.01.006_bib61","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1111\/jgs.19011","article-title":"Factors influencing central nervous system medication deprescribing and behavior change in hospitalized older adults","volume":"72","author":"Pavon","year":"2024","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.sapharm.2026.01.006_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-054279","article-title":"Barriers and facilitators of successful deprescribing as described by older patients living with frailty, their informal carers and clinicians: a qualitative interview study","volume":"12","author":"Peat","year":"2022","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.sapharm.2026.01.006_bib50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12877-020-01972-3","article-title":"Health professionals perception and beliefs about drug- related problems on polymedicated older adults- a focus group study","volume":"21","author":"Pl\u00e1cido","year":"2021","journal-title":"BMC Geriatr"},{"issue":"12","key":"10.1016\/j.sapharm.2026.01.006_bib51","first-page":"636","article-title":"Emotional barriers and facilitators of deprescribing for older adults with cancer and polypharmacy: a qualitative study","volume":"31","author":"Ramsdale","year":"2023","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"issue":"10","key":"10.1016\/j.sapharm.2026.01.006_bib62","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1111\/imj.16512","article-title":"Active deprescribing attitudes and practices in a large regional tertiary health service: a mixed methods study","volume":"54","author":"Robinson","year":"2024","journal-title":"Intern Med J"},{"issue":"6","key":"10.1016\/j.sapharm.2026.01.006_bib52","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1007\/s11096-022-01419-2","article-title":"Beliefs and attitudes of residents, family members and healthcare professionals regarding deprescribing in long-term care: a qualitative study","volume":"44","author":"Rowe","year":"2022","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2026.01.006_bib63","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1186\/s12913-024-11101-0","article-title":"Considerations, barriers and enablers of deprescribing among healthcare professionals in Ogun State, southwest, Nigeria: a cross-sectional survey","volume":"24","author":"Saka","year":"2024","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"10.1016\/j.sapharm.2026.01.006_bib39","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/ageing\/afz133","article-title":"Development of a hospital deprescribing implementation framework: a focus group study with geriatricians and pharmacists","volume":"49","author":"Scott","year":"2019","journal-title":"Age Ageing"},{"issue":"2","key":"10.1016\/j.sapharm.2026.01.006_bib45","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/ageing\/afaa169","article-title":"A practitioner behaviour change intervention for deprescribing in the hospital setting","volume":"50","author":"Scott","year":"2021","journal-title":"Age Ageing"},{"issue":"3","key":"10.1016\/j.sapharm.2026.01.006_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009781","article-title":"What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals","volume":"6","author":"Turner","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.sapharm.2026.01.006_bib65","series-title":"Community Pharmacy at a Glance 2021- Regulation, Scope of Practice, Renumeration and Distribution of Medicines Through Community Pharmacists and Other Outlets","author":"Viegas","year":"2021"},{"key":"10.1016\/j.sapharm.2026.01.006_bib66","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s40545-023-00626-0","article-title":"Global landscape of community pharmacy services remuneration: a narrative synthesis of the literature","volume":"16","author":"Hussain","year":"2023","journal-title":"J Pharm Policy Pract"},{"issue":"6","key":"10.1016\/j.sapharm.2026.01.006_bib67","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/ijpp.12557","article-title":"Barriers to pharmacist prescribing: a scoping review comparing the UK, New Zealand, Canadian and Australian experiences","volume":"27","author":"Zhou","year":"2019","journal-title":"Int J Pharm Pract"},{"issue":"2","key":"10.1016\/j.sapharm.2026.01.006_bib68","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/08404704211063584","article-title":"A framework for interprofessional team collaboration in a hospital setting: advancing team competencies and behaviours","volume":"35","author":"McLaney","year":"2022","journal-title":"Healthc Manage Forum"},{"issue":"6","key":"10.1016\/j.sapharm.2026.01.006_bib69","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.sapharm.2018.08.012","article-title":"Implementing deprescribing guidelines into frontline practice: barriers and facilitators","volume":"15","author":"Conklin","year":"2019","journal-title":"Res Soc Adm Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2026.01.006_bib70","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12913-017-2157-8","article-title":"Perceptions of interprofessional collaboration of general practitioners and community pharmacists - a qualitative study","volume":"17","author":"L\u00f6ffler","year":"2017","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"10.1016\/j.sapharm.2026.01.006_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/intqhc\/mzad110","article-title":"Multidisciplinary perspectives on roles of hospital pharmacists in tertiary care settings: a qualitative study","volume":"36","author":"Lee","year":"2024","journal-title":"Int J Qual Health Care"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741126000070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741126000070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T16:20:32Z","timestamp":1775233232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741126000070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1551741126000070"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2026.01.006","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacists\u2019 barriers and enablers to deprescribing: A systematic review and meta-synthesis","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2026.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}